Cancer Res 61(13):50025009 Lucas RM, McMichael AJ, Armstrong BK, Smith WT (2008) Estimating the global disease burden due to ultraviolet radiation exposure
While semaglutide has been approved for obesity and diabetes, its role in HFpEF is still evolving and has not yet been incorporated into major heart failure guidelines
Life Sci (1996) 58(5):Pl 816
In pernicious anaemia, the immune system mistakenly attacks the gastric parietal cells that produce intrinsic factor, leading to B12 deficiency over time
Clinical Update 7/25/2025 Arthritis Supplements Caution Some "natural" arthritis pain supplements actually contain a prescription medication linked with serious side effects
Semaglutide is a synthetic peptide and long-acting agonist of the glucagon-like peptide-1 (GLP-1) receptor, developed to improve glycemic control in patients with type 2 diabetes and to support weight management